Shanghai Chest Hospital

This study is testing a two-part treatment for advanced non-small cell lung cancer that has started to grow again after initial immunotherapy. It combines a drug (toripalimab) that helps the immune system attack cancer with a procedure (cryoablation) that freezes and destroys a f…

This study is testing whether combining an immunotherapy drug (toripalimab) with targeted radiation works better than combining it with standard chemotherapy when given before surgery for certain stages of non-small cell lung cancer. The goal is to shrink tumors more effectively …

This study is testing a procedure called InterVapor, which uses steam delivered through a bronchoscope to treat damaged parts of the lung in people with severe emphysema. It aims to see if a more precise, targeted treatment is better at improving breathing and quality of life tha…

This study compares two treatments for early, suspicious lung nodules: a minimally invasive freezing procedure called cryoablation and standard keyhole surgery. It aims to see if the freezing treatment is as safe and effective as surgery at keeping patients cancer-free for two ye…

This study is testing a personalized approach for people with advanced lung cancer. It uses a blood test to check for cancer DNA. If the test shows the cancer is responding well, the goal is to see if patients can safely take a break from chemotherapy and continue with a single, …

This early-stage study is testing a new way to treat a serious complication of lung cancer where it spreads to the lining of the brain and spinal cord. Doctors are injecting two cancer drugs directly into the spinal fluid to see if it is safe and if it helps patients live longer.…

This study is testing if adding two types of radiation therapy to standard first-line treatment helps people with advanced esophageal cancer that has spread. About 100 adults who haven't had prior cancer treatment will be randomly assigned to receive either the standard immunothe…

This study is testing whether adding standard chemotherapy to a newer drug called surufatinib works better than surufatinib alone for treating a rare type of lung tumor called a pulmonary neuroendocrine tumor. Researchers will enroll 96 adults who haven't had prior systemic treat…

This study looks back at 400 lung cancer patients who had surgery after receiving drug treatments first. Researchers are comparing traditional open-chest surgery with newer, less invasive techniques. They want to see which approach leads to better recovery and longer survival wit…

This study is testing whether a new robotic system is as good as the current standard method at getting a clear tissue sample from suspicious lung nodules. About 186 adults with these nodules will be randomly assigned to have their biopsy done with either the robotic system or a …

This study aims to understand long-term survival and outcomes for people who have had surgery for esophageal cancer. It will follow over 2,100 patients who had their esophagus removed at participating hospitals. The main goal is to collect information on how patients fare after t…